BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38250151)

  • 1. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through ERK/NFκB axis in Osteosarcoma.
    Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
    Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
    Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
    Arch Toxicol; 2023 Aug; 97(8):2231-2244. PubMed ID: 37314482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-derived advanced glycation end products-Nε-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/reperfusion injury.
    Yang J; Zhang F; Shi H; Gao Y; Dong Z; Ma L; Sun X; Li X; Chang S; Wang Z; Qu Y; Li H; Hu K; Sun A; Ge J
    FASEB J; 2019 Dec; 33(12):14410-14422. PubMed ID: 31665609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.
    Gaens KH; Goossens GH; Niessen PM; van Greevenbroek MM; van der Kallen CJ; Niessen HW; Rensen SS; Buurman WA; Greve JW; Blaak EE; van Zandvoort MA; Bierhaus A; Stehouwer CD; Schalkwijk CG
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1199-208. PubMed ID: 24723555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advanced glycation end-product N
    Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
    J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
    Zhu J; Yang K; Jing Y; Du R; Zhu Z; Lu L; Zhang R
    Cardiovasc Diabetol; 2012 Aug; 11():90. PubMed ID: 22853433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Glycated High Mobility Group Box-1 in Gastric Cancer.
    Kishi S; Nishiguchi Y; Honoki K; Mori S; Fujiwara-Tani R; Sasaki T; Fujii K; Kawahara I; Goto K; Nakashima C; Kido A; Tanaka Y; Luo Y; Kuniyasu H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N
    Wang ZQ; Yao HP; Sun Z
    World J Diabetes; 2023 Mar; 14(3):222-233. PubMed ID: 37035231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotoxicity of Nε-(carboxymethyl)lysine in food processing by a study based on animal and organotypic cell culture.
    Wu Y; Li Y; Zheng L; Wang P; Liu Y; Wu Y; Gong Z
    Ecotoxicol Environ Saf; 2020 Mar; 190():110077. PubMed ID: 31864122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Receptor for Advanced Glycation End Products (Rage) and Its Ligands in Plasma and Infrainguinal Bypass Vein.
    Malmstedt J; Frebelius S; Lengquist M; Jörneskog G; Wang J; Swedenborg J
    Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):579-86. PubMed ID: 26905625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on mechanism of free Nε-(carboxymethyl)lysine-induced toxic injury in mice.
    Wang YX; Xu H; Liu X; Liu L; Wu YN; Gong ZY
    J Biochem Mol Toxicol; 2019 Jul; 33(7):e22322. PubMed ID: 30924232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells.
    Lo MC; Chen MH; Lee WS; Lu CI; Chang CR; Kao SH; Lee HM
    Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E829-39. PubMed ID: 26394662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE/SNAIL1 signaling drives epithelial-mesenchymal plasticity in metastatic triple-negative breast cancer.
    Pujals M; Mayans C; Bellio C; Méndez O; Greco E; Fasani R; Alemany-Chavarria M; Zamora E; Padilla L; Mitjans F; Nuciforo P; Canals F; Nonell L; Abad M; Saura C; Tabernero J; Villanueva J
    Oncogene; 2023 Aug; 42(35):2610-2628. PubMed ID: 37468678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the receptor for advanced glycation end products in hepatic fibrosis.
    Lohwasser C; Neureiter D; Popov Y; Bauer M; Schuppan D
    World J Gastroenterol; 2009 Dec; 15(46):5789-98. PubMed ID: 19998499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression.
    Kislinger T; Fu C; Huber B; Qu W; Taguchi A; Du Yan S; Hofmann M; Yan SF; Pischetsrieder M; Stern D; Schmidt AM
    J Biol Chem; 1999 Oct; 274(44):31740-9. PubMed ID: 10531386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
    Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
    J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer.
    Chen MC; Chen KC; Chang GC; Lin H; Wu CC; Kao WH; Teng CJ; Hsu SL; Yang TY
    Cell Death Dis; 2020 Apr; 11(4):265. PubMed ID: 32327633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice.
    Hansen LM; Gupta D; Joseph G; Weiss D; Taylor WR
    Lab Invest; 2017 Jan; 97(1):34-42. PubMed ID: 27869797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.